Filtros de búsqueda

Lista de obras de

14-3-3σ expression is associated with poor pathological complete response to neoadjuvant chemotherapy in human breast cancers ⬇️

artículo científico publicado el 1 de julio de 2012

A prospective feasibility study applying the ACOSOG Z0011 criteria to Japanese patients with early breast cancer undergoing breast-conserving surgery

artículo científico publicado en 2018

Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer ⬇️

artículo científico publicado el 7 de julio de 2011

Association of GSTP1 methylation with aggressive phenotype in ER-positive breast cancer

artículo científico publicado en 2013

Association of human epidermal growth factor receptor 2 status with ipsilateral breast tumor recurrence and resistance to endocrine therapy

artículo científico publicado en 2015

Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay ⬇️

artículo científico publicado el 19 de mayo de 2011

Efficacy of Scalp Cooling in Preventing and Recovering From Chemotherapy-Induced Alopecia in Breast Cancer Patients: The HOPE Study

scientific article published on 06 August 2019

Estrogen receptor positive breast cancer identified by 95-gene classifier as at high risk for relapse shows better response to neoadjuvant chemotherapy ⬇️

artículo científico publicado el 27 de abril de 2012

Evaluation of Trastuzumab Without Chemotherapy as a Post-operative Adjuvant Therapy in HER2-positive Elderly Breast Cancer Patients: Randomized Controlled Trial [RESPECT (N-SAS BC07)] ⬇️

artículo científico publicado el 24 de febrero de 2011

Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study

scientific article published on 06 December 2019

Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study.

artículo científico publicado en 2017

First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trial.

artículo científico publicado en 2017

Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609 ⬇️

artículo científico publicado el 20 de enero de 2013

Methylated DNA and Total DNA in Serum Detected by One-Step Methylation-Specific PCR Is Predictive of Poor Prognosis for Breast Cancer Patients ⬇️

artículo científico publicado el 5 de septiembre de 2012

Phase I study of combination therapy with weekly paclitaxel and cyclophosphatamide for advanced or recurrent breast cancer.

artículo científico publicado en 2009

Phase II study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer.

artículo científico publicado en 2014

Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B ⬇️

artículo científico publicado el 29 de noviembre de 2011

Randomized phase II study of nab-paclitaxel as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.

artículo científico publicado en 2017

Randomized phase II study of three doses of oral TAS‐108 in postmenopausal patients with metastatic breast cancer ⬇️

artículo científico publicado el 16 de julio de 2012

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil– epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to ne

artículo científico publicado en 2013

Regional lymphatic recurrence after salvage surgery for ipsilateral breast tumor recurrence of breast cancer without local treatment for regional lymphatic basin

artículo científico publicado en 2014

Reliability of Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Expression on Breast Cancer Cells Stored in Cellprep® Vials

artículo científico publicado en 2018

Safety for Repeat Lumpectomy Without Radiotherapy for Ipsilateral Breast Tumor Recurrence

artículo científico publicado en 2017

Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study ⬇️

artículo científico publicado el 28 de abril de 2011

Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer

artículo científico publicado en 2015

Therapy options after CDK4/6 inhibitors for HR+, HER2- postmenopausal metastatic/recurrent breast cancer in Japan: a role for mammalian target of rapamycin inhibitors?

artículo científico publicado en 2020

Transaxillary endoscopic partial mastectomy for comparatively early-stage breast cancer. An early experience

artículo científico publicado el 1 de agosto de 1998

Treatment sequence of aromatase inhibitors and radiotherapy and long-term outcomes of breast cancer patients

artículo científico publicado en 2014

pTis and pT1a Ipsilateral Breast Tumor Recurrence Is Associated with Good Prognosis after Salvage Surgery

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda